These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 18089967)

  • 1. Minimization of immunosuppression in kidney transplantation.
    Augustine JJ; Hricik DE
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):535-41. PubMed ID: 18089967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
    Helal I; Chan L
    Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid sparing in kidney transplantation: changing paradigms, improving outcomes, and remaining questions.
    Augustine JJ; Hricik DE
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1080-9. PubMed ID: 17699329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug insight: maintenance immunosuppression in kidney transplant recipients.
    Samaniego M; Becker BN; Djamali A
    Nat Clin Pract Nephrol; 2006 Dec; 2(12):688-99. PubMed ID: 17124526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for immunosuppression in lung transplantation.
    Hopkins PM; McNeil K
    Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in immunosuppression for pancreas transplantation.
    Singh RP; Stratta RJ
    Curr Opin Organ Transplant; 2008 Feb; 13(1):79-84. PubMed ID: 18660711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid avoidance or withdrawal in kidney transplantation.
    Pascual J
    Curr Opin Organ Transplant; 2011 Dec; 16(6):600-5. PubMed ID: 21971514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcineurin inhibitor-free immunosuppression in kidney transplantation.
    Guerra G; Srinivas TR; Meier-Kriesche HU
    Transpl Int; 2007 Oct; 20(10):813-27. PubMed ID: 17645419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimization and withdrawal of steroids in pancreas and islet transplantation.
    Mineo D; Sageshima J; Burke GW; Ricordi C
    Transpl Int; 2009 Jan; 22(1):20-37. PubMed ID: 18855850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid-free immunosuppression in kidney transplant recipients: the University of Minnesota experience.
    Humar A; Dunn T; Kandaswamy R; Payne WD; Sutherland DE; Matas AJ
    Clin Transpl; 2007; ():43-50. PubMed ID: 18637457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients.
    Vincenti F
    Transpl Int; 2004 Sep; 17(8):395-401. PubMed ID: 15365604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance.
    Yang H
    Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S37-51. PubMed ID: 16567240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
    Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
    Clin Transplant; 2008; 22(5):645-50. PubMed ID: 18657156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of renal dysfunction in the liver transplant recipient.
    Pham PT; Pham PC; Wilkinson AH
    Curr Opin Organ Transplant; 2009 Jun; 14(3):231-9. PubMed ID: 19395967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-sparing strategies.
    Ponticelli C
    Transplant Proc; 2005 Nov; 37(9):3597-9. PubMed ID: 16386481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Out with the old, in with the new: immunosuppression minimization in children.
    Sarwal MM
    Curr Opin Organ Transplant; 2008 Oct; 13(5):513-21. PubMed ID: 19060535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
    Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES
    Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal protective strategies in heart transplant patients.
    Cantarovich M
    Curr Opin Cardiol; 2007 Mar; 22(2):133-8. PubMed ID: 17284993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.